Since intraperitoneal injection of bexarotene decreased CXCL5 and CXCL10 mRNA expression in EL4 mouse T-cell lymphoma in vivo, we evaluated serum levels of these chemokines in patients with early and advanced CTCL. Here, CXCL10 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.